Broncus Medical Wins NMPA Approval for BroncAblate RFA System Console
Shanghai and Hangzhou (China), and San Jose and Seattle (United States)-based Broncus Medical (HKG: 2216)...
Broncus Medical
Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment
Broncus Medical Inc. (HKG: 2216), a provider of precision intervention solutions for lung disease, announced...
Broncus Medical’s BroncQCT Approved by Zhejiang Administration for China Market Entry
Broncus Medical Inc., a provider of precision intervention solutions for lung diseases with operations in...
Broncus Medical Inc. Reports 32% YOY Growth in 2023, Highlighted by Strength in China
Broncus Medical Inc. (HKG: 2216), a provider of precision intervention solutions for lung diseases with...
Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee
Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...
Broncus Medical Inc. to Acquire Fibernova Holding Corporation for USD 2.7 Million
Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...
Broncus Medical Inc. Launches First Regulatory Clinical Study for Targeted Lung Denervation System
China-based Broncus Medical Inc., (HKG: 2216), a provider of precision intervention solutions focused on lung...
Broncus Medical and Venus Medtech Establish Joint Venture Fund for Digital Medical Equipment
Broncus Medical Inc., (HKG: 2216) a leading provider of lung disease precision intervention solutions based...